Navigation Links
New Monograph Spotlights Urgent Need for Congress to Get Neurotoxins and Other Poisons Out of Vaccines
Date:1/31/2011

WASHINGTON, Jan. 31, 2011 /PRNewswire/ -- With the latest round of flu vaccine damage surfacing in mid-January, the FDA is again investigating the association between vaccines and febrile seizures in children. How often do health consumers need the "wool pulled over their eyes" about vaccines? It's time for Congress to challenge the "safe and effective" mantra of Big Pharma and the medical industry.  

The January 2011 monograph Vaccines & Vaccinations: The Need for Congressional Investigation (edited by Catherine J Frompovich and Laraine C Abbey) documents the presence of toxins, including brain and nervous system damaging adjuvants, excipients, and growth medium in vaccines that can cause health damage to everyone -- especially to children and pregnant women.

The monograph uses peer-reviewed journals, CDC, FDA, HHS, and other accepted sources regarding vaccines/vaccinations to connect the dots on what is NOT being shared with health consumers (nor most health professionals) about vaccinations, e.g., toxic adjuvants like aluminum -- a neurotoxin; mercury -- a neurotoxic hazmat; formaldehyde -- an EPA-declared carcinogen; MSG -- an excitotoxin that stimulates brain cells to self-destruction; polysorbate 80 -- causes infertility in lab rats; diploid (aborted human fetal) cells; foreign DNA from dogs, chicks, monkeys, and insects; plus many more, which should not be injected into babies immediately after birth -- or any time.

One-sixth (1/6th) of U.S. children are neurodevelopmentally damaged, with one in a hundred (1 per 100) victims of autism. Many more children suffer with other chronic health problems, including cancer and autoimmune disorders, both of which have been linked, in part, to vaccines. Autoimmune disorders include diabetes, asthma, and allergies. Such associations must be investigated and not by Big Pharma, who supplies FDA with often-skewed research indicating that neurotoxic adjuvants are "safe."

This monograph delivers much-needed information to legislators, health professionals, and consumers regarding the facts about vaccines.

Pharmaceutical forces driving the vaccine agenda are powerful, but so is the rising tide of concerned professionals and citizens. It is time for Congress to seriously investigate vaccines and vaccinations.

Contact:

Catherine J Frompovich; catherinejfrompovich@ymail.com; 215-653-7575
Laraine C Abbey; betterfoodforbetterkids@yahoo.com; 732-475-2754
Contact either editor by email for a free PDF copy of the 150-page document.



This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Catherine J Frompovich; Laraine C Abbey
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New FDLI Monograph Provides Expert Guidance on Selling Pharmaceuticals, Biologics to Federal Government
2. Varian Medical Systems Spotlights TrueBeam Treatment System for First Time in Europe at ESTRO 2010, September 12-16, Barcelona
3. Total Federal Grant Funds for Indiana Health Information Technology Efforts Climb to Nearly $50 Million; Latest $16 Million Installment Spotlights Indiana Health Information Exchange in Delivering Higher Quality and Higher Value Healthcare Through M
4. Additional Regional Medicare Carrier Initiates Coverage for Posterior Tibial Nerve Stimulation (PTNS) Delivered via Uroplastys Urgent® PC Neuromodulation System
5. Coverage Initiated by Two Regional Medicare Carriers for Posterior Tibial Nerve Stimulation (PTNS) Delivered Via Uroplastys Urgent® PC Neuromodulation System
6. Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
7. Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule
8. Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention
9. Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial
10. Resurgent Health and Medical Announces That Childrens Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems
11. Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the leading ... with Tennessee Counseling Association. This new relationship allows TherapySites to continue ... Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited about ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, ... the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where ... city’s history as home to some of the world’s leading providers of cereal and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
Breaking Medicine News(10 mins):